|
In 2003, the International Breast Cancer Study Group IBCSG initiated two randomized, phase 3 trials, the Suppression of Ovarian Function Trial SOFT and the Tamoxifen and Exemestane Trial TEXT, involving premenopausal women with hormone receptor positive early breast cancer
|
|